Looking for Neuro-Level? Neuro Level, a previous MHF product has been replaced with Neuro-Replete. Neuro-Replete contains ingredients very similar to and produces results very similar to that of Neuro-Level. From a clinical standpoint they are used for the same indications.
- Technical Specs
Neuro Replete’s clinically researched formula addresses a critical area of neurotransmitter health that many formulas have overlooked — the need for balanced amino acid precursor administration. NeuroReplete is formulated based on research that started in 1995 and provides premium nutrients which support brain, gut and overall health. NeuroReplete’s balanced nutrient formula supports serotonin, dopamine, norepinephrine and epinephrine production in proper ratio. Serotonin is associated with mood, appetite, sleep, memory, learning, and temperature regulation. Dopamine, norepinephrine and epinephrine (the catecholamines) are associated with control of movement, balance, motivation, focus, addiction and the drive for reward.
- NeuroReplete provides balanced nutrients to support serotonin, dopamine, norepinephrine and epinephrine production
- NeuroReplete supports the enteric nervous system, which is associated with gastrointestinal health (Gut health)
- NeuroReplete supports healthy neurotransmitter levels
- NeuroReplete promotes brain health and wellness
- NeuroReplete promotes post-synaptic neuron firing
- NeuroReplete provides 5-HTP, which supports a normal feeling of well-being
- NeuroReplete provides 5-HTP, which supports normal appetite
- NeuroReplete provides 5-HTP, which supports normal sleep
- NeuroReplete provides 5-HTP, which supports normal memory and learning
- NeuroReplete provides L-tyrosine, which promotes normal control of movement
- NeuroReplete provides L-tyrosine, which promotes normal balance
- NeuroReplete provides L-tyrosine, which supports normal motivation
- NeuroReplete provides L-tyrosine, which supports normal focus
- NeuroReplete provides L-tyrosine, which supports nutrient needs associated with addiction
Suggested Dosage - 240 Count
2 to 4 capsules twice per day (preferably in the morning and late afternoon)or as directed by a healthcare professional
Ingredients (Serving Size 4 Capsules)
Vitamin C 500mg
Vitamin B6 (P-5-P) 37.5mg
Folate (folic Acid) 200mcg
Calcium (Calcium Citrate) 110mg
- Extended Information
People with strong sulfur allergies should not use this product as L-Cysteine and L-Methionine are sulfur forming amino acids. Anyone taking antidepressant or mood stabilizing drugs should consult with their health care provider before using this product.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Marty Hinz, Alvin Stein. Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation. Published Date January 2011 Volume 2011:7(1) Pages 31 – 38
Kohlstadt I, Hinz M. Food and Nutrients in Disease Management. CRC Press 2008
Hirschfeld RM. History & evolution of the monoamine hypothesis of depression. J Clin Psychiatry.2000;61 Suppl:4–6.
Pyle AC, Argyropoulos SV, Nutt DJ. The role of serotonin in panic: evidence from tryptophan depletion studies. Acta Neuropsychiatrica 2004; 16:79–84.
Verde G, Oppizzi G, Colussi G, Cremascoli G, Botalla L, Muller EE, Silvestrini F, Chiodini PG, Liuzzi A. Effect of dopamine infusion on plasma levels of growth hormone in normal subjects and in agromegalic patients. Clin Endocrinol (Oxf). 1976 Jul; 5(4):419–423.
Blundell JE, Leshem MB. The effect of 5-hydroxytryptophan on food intake and on the anorexic action of amphetamine and fenfluramine. J Pharm Pharmacol 1975;27:31-7.
Cangiano C, Ceci F, Cairella M, Cascino A, Del Ben M, Laviano A, Muscaritoli M, Rossi-Fanelli F. Effects of 5-hydroxytryptophan on eating behavior and adherence to dietary prescriptions in obese adult subjects. Adv Exp Med Biol 1991;294:591-3.
Cangiano C, Ceci F, Cascino A, Del Ben M, Laviano A, Muscaritoli M, Antonucci F, Rossi-Fanelli F. Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan. AmJ Clin Nutr 1992;56:863-7.
Fernstrom JD. Dietary amino acids and brain function. J Am Diet Assoc. 1994 Jan;94(1):71-7.
Fernstrom JD. Dietary precursors and brain neurotransmitter formation. Annu Rev Med. 1981;32:413-25.
Growdon JH, Wurtman RJ. Nutrients and neurotransmitters. N Y State J Med. 1980 Sep;80(10):1638-9.
Kadrabová J, Madaric A, Kováciková Z, Ginter E. Selenium status, plasma zinc, copper, and magnesium in vegetarians. Biol Trace Elem Res 1995;50:13-24.
Lehr D. A possible beneficial effect of selenium administration in antiarrhythmic therapy. J Am Coll Nutr1994;13:496-498.
Olmsted L, Schrauzer GN, Flores-Arce M, Dowd J. Selenium supplementation of symptomatic human mmunodeficiency virus infected patients. Biol Trace Elem Res 1989;20:59-65.
Sun E, Xu H, Liu Q, Zhou J, Zuo P, Wang J. The mechanism for the effect of selenium supplementation on immunity. Biol Trace Elem Res 1995;48:231-238.
Gerhard N. Schrauzer . Selenomethionine: A Review of Its Nutritional Significance, Metabolism and Toxicity12 Journal of Nutrition. 2000;130:1653-1656.
Yiming Xia, Kristina E Hill, Ping Li, Jiayuan Xu, Dingyou Zhou, Amy K Motley, Li Wang, Daniel W Byrne and Raymond F Burk. Optimization of selenoprotein P and other plasma selenium biomarkers for the assessment of the selenium nutritional requirement: a placebo-controlled double-blind study of elenomethionine supplementation in selenium-deficient Chinese subjects. Am J Clin Nutr doi:10.3945/ajcn.2010.29642
McAuley DF, Hanratty CG, McGurk C, et al. Effect of methionine supplementation on endothelial function, plasma homocysteine, and lipid peroxidation. J Toxicol Clin Toxicol 1999;37:435–40.
Toborek M, Hennig B. Is methionine an atherogenic amino acid? J Optimal Nutr 1994;3:80–3. The effect of methionine and S-adenosylmethionine on S-adenosylmethionine levels in the rat brain. J Psychiatry Neurosci. 2005 Jan;30(1):44-8.
Johri SK. L-tyrosine pharmacotherapy of schizophrenia: preliminary data. Clin Neuropharmacol 1994;17:53-62.
Elwes RD, Crewes H, Chesterman LP, et al. Treatment of narcolepsy with L-tyrosine: double-blind placebo-controlled trial. Lancet 1989;2:1067-1069.
Lou HC, Lykkelund C, Gerdes AM, Udesen H, Bruhn P. Increased vigilance and dopamine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria. Acta Paediatr Scand 1987;76:560-565.
Neri DF, Wiegmann D, Stanny RR, Shappell SA, McCardie A, McKay DL. The effects of tyrosine on cognitive performance during extended wakefulness. Aviat Space Environ Med 1995;66:313-319.
Salter CA. Dietary tyrosine as an aid to stress resistance among troops. Mil Med 1989;154:144-146.
Shurtleff D, Thomas JR, Schrot J, Kowalski K, Harford R. Tyrosine reverses a cold-induced working memory deficit in humans. Pharmacol Biochem Behav 1994;47:935-941.
Sole MJ, Benedict CR, Myers MG, Leenen FH, Anderson GH. Chronic dietary tyrosine supplements do not affect mild essential hypertension. Hypertension 1985;7:593-596.
Zeisel SH. Dietary influences on neurotransmission. Adv Pediatr 1995;33:23-47.
JG, Eskes TK, Steegers-Theunissen RP. Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial. Am J Clin Nutr 1999;69:99-104.
Den Heijer M, Brouwer IA, Bos GM, Blom HJ, van der Put NM, Spaans AP, Rosendaal FR, Thomas CM, Haak HL,